Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Godavari Drugs Financial Results

Godavari Drugs Ltd reported annual revenue of ₹105.81 Crore for FY2026. The Board approved the audited results and appointed new internal and cost auditors.

Key figures
Value₹105.8 Cr
Source

BSE filing, NSE: GODAVARI. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Godavari Drugs Ltd: key numbers

Share price
₹121.00
Market cap
₹122.5 Cr
Revenue (annual)
₹105.8 Cr
Net profit (annual)
₹4.09 Cr
P/E (TTM)
29.5×Sector 46.1×
Promoter holding
40.23%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Godavari Drugs Ltd

All →

Other financial results announcements

All →